MODELLING INTERACTOMES RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON How does the genome of an organism specify its behaviour and characteristics?

Slides:



Advertisements
Similar presentations
MitoInteractome : Mitochondrial Protein Interactome Database Rohit Reja Korean Bioinformation Center, Daejeon, Korea.
Advertisements

 A cell is an organization of millions of molecules  Proper communication between these molecules is essential to the normal functioning of the cell.
VISION META CORPORATION TheRx (holding company) Self funded License patents from UW 1.Docking with dynamics, multitargeting, new use, herpes, malaria,
Genome-wide prediction and characterization of interactions between transcription factors in S. cerevisiae Speaker: Chunhui Cai.
Genetics: From Genes to Genomes
Epistasis Analysis Using Microarrays Chris Workman.
Protein Interactions and Disease Audry Kang 7/15/2013.
Proteomics Understanding Proteins in the Postgenomic Era.
Bioinformatics for biomedicine Protein domains and 3D structure Lecture 4, Per Kraulis
Elements of Molecular Biology All living things are made of cells All living things are made of cells Prokaryote, Eukaryote Prokaryote, Eukaryote.
NOVEL PARADIGMS FOR DRUG DISCOVERY SHOTGUN COMPUTATIONAL MULTITARGET SCREENING RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON PIONEER AWARD.
Modelling, comparison, and analysis of proteomes Ram Samudrala University of Washington.
Structural Bioinformatics R. Sowdhamini National Centre for Biological Sciences Tata Institute of Fundamental Research Bangalore, INDIA.
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
Consensus RAPDF rTAD Refinement Successes & Failures Jeremy Horst Ram Samudrala’s CompBio Group University of Washington.
Modelling proteomes An integrated computational framework for systems biology research Ram Samudrala University of Washington How does the genome of an.
Introduction to Bioinformatics Spring 2002 Adapted from Irit Orr Course at WIS.
COMPUTATIONAL VACCINE DESIGN RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON How can we design vaccines based on conformational epitopes and.
Finish up array applications Move on to proteomics Protein microarrays.
Function first: a powerful approach to post-genomic drug discovery Stephen F. Betz, Susan M. Baxter and Jacquelyn S. Fetrow GeneFormatics Presented by.
Modelling Genome Structure and Function Ram Samudrala University of Washington.
Samudrala group - overall research areas CASP6 prediction for T Å C α RMSD for all 70 residues CASP6 prediction for T Å C α RMSD for all.
An Integrated Computational Framework for Systems Biology Ram Samudrala University of Washington How does the genome of an organism specify its behaviour.
SHOTGUN STRUCTURAL PROTEOMICS RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON Given a heterogeneous mixture of proteins, how can we determine.
Genomes To Life Biology for 21 st Century A Joint Initiative of the Office of Advanced Scientific Computing Research and Office of Biological and Environmental.
INTERACTOMICS RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON NIH DIRECTOR’S PIONEER AWARD 2010 How does the genome of an organism specify its.
Biological Signal Detection for Protein Function Prediction Investigators: Yang Dai Prime Grant Support: NSF Problem Statement and Motivation Technical.
Lecture 9. Functional Genomics at the Protein Level: Proteomics.
Six plasmids for NC5 sample expression and 2D [ 1 H, 15 N] HSQC screening  Rossmann2x3_58: OR25  Rossmann2x3_59: OR26  Rossmann2x3_61: OR27  Rossmann2x3_71:
NOVEL PARADIGMS FOR DRUG DISCOVERY SHOTGUN COMPUTATIONAL MULTITARGET SCREENING RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON NIH DIRECTOR’S.
Computational engineering of bionanostructures Ram Samudrala University of Washington How can we analyse, design, & engineer peptides capable of specific.
Proteomics Session 1 Introduction. Some basic concepts in biology and biochemistry.
THERAPUETIC DISCOVERY BY MODELLING INTERACTOMES RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON How does the genome of an organism specify its.
Bioinformatics and Computational Biology
COMPUTATIONAL ENGINEERING OF BIONANOSTRUCTURES
Introduction to biological molecular networks
MODELLING INTERACTOMES RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON How does the genome of an organism specify its behaviour and characteristics?
Modelling proteomes Ram Samudrala Department of Microbiology How does the genome of an organism specify its behaviour and characteristics?
COMPUTATIONAL BIOLOGY IN DRUG DISCOVERY RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON How can we computationally screen compounds against.
NOVEL PARADIGMS FOR DRUG DISCOVERY
 Six designs (OR25, OR26, OR27, OR28, OR29, OR30) for 2D [ 1 H, 15 N] HSQC screening  OR28 for structure determination Gaohua Liu 1, Nobuyasu Koga 2,
MODELLING PROTEOMES RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON How does the genome of an organism specify its behaviour and characteristics?
Modelling proteomes Ram Samudrala University of Washington How does the genome of an organism specify its behaviour and characteristics?
Modelling proteins and proteomes using Linux clusters Ram Samudrala University of Washington.
SHOTGUN STRUCTURAL PROTEOMICS RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON Given a heterogeneous mixture of proteins, how can we determine.
Discovery of Therapeutics to Improve Quality of Life Ram Samudrala University of Washington.
Modelling proteomes Ram Samudrala University of Washington.
Modelling proteomes: Application to understanding HIV disease progression Ram Samudrala Department of Microbiology University of Washington How does the.
COMPUTATIONAL ENGINEERING OF BIONANOSTRUCTURES RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON How can we design peptides and proteins capable.
Modelling genome structure and function Ram Samudrala University of Washington.
Modelling Genome Structure and Function Ram Samudrala University of Washington.
Modelling proteomes Ram Samudrala University of Washington How does the genome of an organism specify its behaviour and characteristics?
MODELLING PROTEOMES RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON How does the genome of an organism specify its behaviour and characteristics?
Molecular Modeling in Drug Discovery: an Overview
Structural Bioinformatics Elodie Laine Master BIM-BMC Semester 3, Genomics of Microorganisms, UMR 7238, CNRS-UPMC e-documents:
Bioinformatics Overview
High-throughput data used in bioinformatics
How does the genome of an organism
University of Washington
MODELLING INTERACTOMES
Modelling the rice proteome
MODELLING INTERACTOMES
University of Washington
Molecular Docking Profacgen. The interactions between proteins and other molecules play important roles in various biological processes, including gene.
Proteomics Informatics David Fenyő
Department of Chemical Engineering
How does the genome of an organism
University of Washington
NOVEL PARADIGMS FOR DRUG DISCOVERY
Proteomics Informatics David Fenyő
Presentation transcript:

MODELLING INTERACTOMES RAM SAMUDRALA ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON How does the genome of an organism specify its behaviour and characteristics? How can we use this information to improve human health and quality of life?

MOTIVATION The functions necessary for life are undertaken by proteins and their interactions (with other proteins, DNA, RNA, and small molecules). Protein function is mediated by atomic three dimensional structure. Knowing protein structure at atomic resolution will therefore enable us to: Determine and understand molecular function. Understand substrate and ligand binding interactions. Devise intelligent mutagenesis and biochemical. experiments to understand biological function. Design therapeutics rationally. Design novel proteins. Knowing the atomic level structures of all proteins encoded by an organism’s genome, along with interactions, will enable us to understand the underlying mechanistic basis or “wiring diagram” that comprises pathways, systems, and organisms. Applications in the area of medicine, nanotechnology, and biological computing.

PROTEOME ~30,000 in human ~60,000 in rice ~4500 in bacteria Several thousand distinct sequence families countless numbers total

STRUCTURE A few thousand distinct structural folds

FUNCTION Tens of thousands of functions

EXPRESSION Different expression patterns based on time and location

INTERACTION Interaction and expression are interdependent with structure and function

PROTEIN FOLDING …-CTA-AAA-GAA-GGT-GTT-AGC-AAG-GTT-… Gene …-L-K-E-G-V-S-K-D-… One amino acid Protein sequence Unfolded protein Native biologically relevant state Spontaneous self-organisation (~1 second) Not unique Mobile Inactive Expanded Irregular

PROTEIN FOLDING …-L-K-E-G-V-S-K-D-… …-CTA-AAA-GAA-GGT-GTT-AGC-AAG-GTT-… One amino acid Gene Protein sequence Unfolded protein Native biologically relevant state Spontaneous self-organisation (~1 second) Unique shape Precisely ordered Stable/functional Globular/compact Helices and sheets Not unique Mobile Inactive Expanded Irregular

STRUCTURE 0246 ACCURACY Experiment (X-ray, NMR) Computation (de novo) Computation (template-based) Hybrid (Iterative Bayesian interpretation of noisy NMR data with structure simulations) One distance constraint for every six residues One distance constraint for every ten residues C α RMSD

STRUCTURE 0.5 Å C α RMSD for 173 residues (60% identity) T0290 – peptidyl-prolyl isomerase from H. sapiens T0364 – hypothetical from P. putida 5.3 Å C α RMSD for 153 residues (11% identity) T0332 – methyltransferase from H. sapiens 2.0 Å C α RMSD for 159 residues (23% identity) T0288 – PRKCA-binding from H. sapiens 2.2 Å C α RMSD for 93 residues (25% identity) Liu/Hong-Hung/Ngan

FUNCTION Wang/Cheng Ion binding energy prediction with a correlation of 0.7 Calcium ions predicted to < 0.05 Å RMSD in 130 cases Meta-functional signature for DXS model from M. tuberculosis Meta-functional signature accuracy

INTERACTION McDermott/Wichadakul/Staley/Horst/Manocheewa/Jenwitheesuk/Bernard BtubA/BtubB interolog model from P. dejongeii (35% identity to eukaryotic tubulins) Transcription factor bound to DNA promoter regulog model from S. cerevisiae Prediction of binding energies of HIV protease mutants and inhibitors using docking with dynamics

SYSTEMS McDermott/Wichadakul Example predicted protein interaction network from M. tuberculosis (107 proteins with 762 unique interactions) In sum, we can predict functions for more than 50% of a proteome, approximately ten million protein-protein and protein-DNA interactions with an expected accuracy of 50%. Utility in identifying function, essential proteins, and host pathogen interactions Proteins PPIs TRIs H. sapiens 26,741 17, ,807 1,045,622 S. cerevisiae 5,801 5, ,505 2,456 O.sativa (6) 125,568 19, , ,990 E. coli 4, ,980 54,619

SYSTEMS McDermott/Rashid/Wichadakul Combining protein-protein and protein-DNA interaction networks to determine regulatory circuits

INFRASTRUCTURE Guerquin/Frazier ~500,000 molecules over 50+proteomes served using a 1.2 TB PostgreSQL database and a sophisticated AJAX webapplication and XML-RPC API

INFRASTRUCTURE Guerquin/Frazier

INFRASTRUCTURE Chang/Rashid

Disease Target identification Single disease related protein Multiple disease related proteins Compound library Small molecule library DRUG-LIKE COMPOUNDS High throughput screening Computational screening Computational screening with dynamics Initial candidates Initial candidates Experimental verification Experimental verification Experimental verification Success rate+ Success rate ++ Success rate Time++++Time +++ Time +++ Cost++++ Cost +++ Cost + SINGLE TARGET SCREENING MULTITARGET SCREENING Jenwitheesuk APPLICATION: DRUG DISCOVERY

HSV KHSVCMV Jenwitheesuk

APPLICATION: DRUG DISCOVERY

HSV KHSV CMV Computionally predicted broad spectrum human herpesvirus protease inhibitors is effective in vitro against members from all three classes and is comparable or better than anti-herpes drugs HSV Our protease inhibitor acts synergistically with acylovir (a nucleoside analogue that inhibits replication) and it is less likely to lead to resistant strains compared to acylovir Lagunoff

APPLICATION: RICE INTERACTOMICS Proteome Number Number Number Number of annotated in of proteins (%) protein protein network interactions O. sativa japonica KOME cDNAs 25,875 11,841 (44%) ,102 O. sativa indica BGI ,925 22,278 (55%) ,149 O. sativa japonica Syngenta 38,071 20,874 (55%) ,640 O. sativa indica IRGSP 36,658 20,481 (56%) ,118 O. sativa japonica nrKOME cDNAs 19, (39%) ,793 O. sativa indica BGI pa64 37,712 15,286 (41%) ,779 Total 198,298 98,238 (50%) 31, ,581 Total (unique) 125,568 60,272 (48%) 19, , BGI/McDermott/Wichadakul

APPLICATION: RICE INTERACTOMICS BGI/McDermott

APPLICATION: NANOTECHNOLOGY Oren/Sarikaya/Tamerler

Principal protein involved in enamel and hard tissue formation. Multifunction protein: –Mineralisation. –Signaling. –Adhesion to process matrix. –Physical protein-protein interactions. Never been crystallised (irregular/unstable?). –Most proteins with non-repeating sequence are active in globular form. –Many proteins fold into globular form upon interaction with substrate / interactor. –Assumption of linear and globular forms. –Goal is to understand protein structure, function, binding to hydroxyapatite, interaction with other amelogenin molecules, and formation of enamel and hard tissue formation APPLICATION: AMELOGENIN

Predicted five models (typical for CASP). Annotate structure with experimental and simulation evidence to find best predicted globular structure and infer function.

MGTWILFACLLGAAFAMPLPPHPGSPGYINLSYEKSHSQAINTDRTALVLTPLKWYQSMIRQPYPSYGYEPMGGWLHHQIIPVLSQQHPPSHTLQPHHHLPVVPAQQPVA PQQPMMPVPGHHSMTPTQHHQPNIPPSAQQPFQQPFQPQAIPPQSHQPMQPQSPLHPMQPLAPQPPLPPLFSMQPLSPILPELPLEAWPATDKTKREEVD Signal Region Exon 4 APPLICATION: AMELOGENIN Horst/Oren/Cheng/Wang

FUTURE Structural genomics Functional genomics + Computational biology + MODELLING PROTEIN AND PROTEOME STRUCTURE FUNCTION AT THE ATOMIC LEVEL IS NECESSARY TO UNDERSTAND THE RELATIONSHIPS BETWEEN SINGLE MOLECULES, SYSTEMS, PATHWAYS, CELLS, AND ORGANISMS

ACKNOWLEDGEMENTS Baishali Chanda Brady Bernard Chuck Mader Ersin Emre Oren Gong Cheng Imran Rashid Jeremy Horst Ling-Hong Hung Michal Guerquin Shu Feng Siriphan Manocheewa Somsak Phattarasukol Stewart Moughon Tianyun Liu Vania Wang Weerayuth Kittichotirat Zach Frazier Reene Ireton, Program Manager Current group members: Aaron Chang David Nickle Duangdao Wichadukul Duncan Milburn Ekachai Jenwitheesuk Jason McDermott Marissa LaMadrid Kai Wang Kristina Montgomery Sarunya Suebtragoon Shing-Chung Ngan Vanessa Steinhilb Yi-Ling Cheng Past group members:

ACKNOWLEDGEMENTS Funding agencies: National Institutes of Health National Science Foundation -DBI -IIS Searle Scholars Program Puget Sound Partners in Global Health Washington Research Foundation UW -Advanced Technology Initiative -TGIF BGI -Gane Wong -Jun Yu -Jun Wang -et al. BIOTEC/KMUTT MSE -Mehmet Sarikaya -Candan Tamerler -et al. UW Microbiology -James Staley -John Mittler -Michael Lagunoff -Roger Bumgarner -Wesley Van Voorhis -et al. Collaborators:

E. coli INTERACTIONS McDermott

M. tuberculosis INTERACTIONS McDermott

C. elegans INTERACTIONS McDermott

H. sapiens INTERACTIONS McDermott

Network-based annotation for C. elegans McDermott

Articulation points KEY PROTEINS IN ANTHRAX

HOST PATHOGEN INTERACTIONS McDermott